Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IP9V
|
|||
Former ID |
DNC008508
|
|||
Drug Name |
PH-709829
|
|||
Synonyms |
PTGWFYYEAUFEAS-ZYHUDNBSSA-N; CHEMBL403858; PHA-709829; SCHEMBL844377; GTPL3997; BDBM50377050
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
C15H17N3O2
|
|||
Canonical SMILES |
C1CN2CC1CC(C2)NC(=O)C3=NC=C4C(=C3)C=CO4
|
|||
InChI |
1S/C15H17N3O2/c19-15(13-6-11-2-4-20-14(11)7-16-13)17-12-5-10-1-3-18(8-10)9-12/h2,4,6-7,10,12H,1,3,5,8-9H2,(H,17,19)/t10-,12-/m1/s1
|
|||
InChIKey |
PTGWFYYEAUFEAS-ZYHUDNBSSA-N
|
|||
CAS Number |
CAS 508202-22-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 3A receptor (HTR3A) | Target Info | Inhibitor | [2] |
Neuronal acetylcholine receptor alpha-7 (CHRNA7) | Target Info | Inhibitor | [2] | |
KEGG Pathway | Serotonergic synapse | |||
Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Cholinergic synapse | ||||
Nicotine addiction | ||||
Chemical carcinogenesis | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Panther Pathway | 5HT3 type receptor mediated signaling pathway | |||
Alzheimer disease-amyloid secretase pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
Reactome | Ligand-gated ion channel transport | |||
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Iron uptake and transport | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3997). | |||
REF 2 | Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor:... Bioorg Med Chem Lett. 2008 Jun 15;18(12):3611-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.